Status:
COMPLETED
Transfusions and Nitric Oxide Level in Preterm Infants
Lead Sponsor:
Duke University
Collaborating Sponsors:
Children's Miracle Network
Conditions:
Prematurity
Anemia
Eligibility:
All Genders
Up to 365 years
Brief Summary
The purpose of this study is to better understand S-nitrosohemeglobin (SNO-Hb) in transfused blood of extremely preterm infants. The long term goal of the project is to identify variation in the SNO-H...
Eligibility Criteria
Inclusion
- Infant \< 28 weeks gestation at birth
- Undergoing PRBC transfusion with a volume ≥ 10 cc/kg
- Availability and willingness of the parent/legally authorized representative to provide written informed consent.
Exclusion
- Any concomitant condition, which in the opinion of the investigator would preclude a patient's participation in the study
- Previous participation in the study.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00787124
Start Date
September 1 2008
End Date
September 1 2009
Last Update
September 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710